Literature DB >> 30268719

Correlation Between Intravoxel Incoherent Motion and Dynamic Contrast-Enhanced Magnetic Resonance Imaging Parameters in Rectal Cancer.

Hongliang Sun1, Yanyan Xu2, Qiaoyu Xu2, Jianghui Duan2, Haibo Zhang2, Tongxi Liu2, Lu Li2, Queenie Chan3, Sheng Xie2, Wu Wang2.   

Abstract

RATIONALE AND
OBJECTIVES: This study aimed to determine the correlation between intravoxel incoherent motion (IVIM) and multiphase dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) quantitative parameters in patients with rectal cancer.
MATERIALS AND METHODS: Ninety-seven patients with rectal cancer were included in this study. All pelvic MRI examinations were performed in a 3.0 T MR unit, including diffusion-weighted imaging with 16 b values, DCE-MRI with two different flip angles (5° and 10°, respectively), and T1-fast field echo sequences as the reference. The IVIM perfusion-related parameters (f, perfusion fraction; D*, pseudo-diffusion coefficient; f·D*, the multiplication of the two parameters) were calculated by biexponential analysis. Quantitative DCE-MRI parameters were transfer constant (Ktrans) between blood plasma and extravascular extracellular space), Kep (rate between extravascular extracellular space and blood plasma), Ve (extravascular volume fraction), Vp (plasma volume fraction), and area under the gadolinium concentration curve. Interobserver agreements were evaluated using the intraclass correlation coefficient and Bland-Altman analysis. A p value <0.05 indicated a statistically significant difference.
RESULTS: The study included 75 males and 22 females with a median age of 58.8 years (range, 26-85years). Interobserver reproducibility for IVIM perfusion-related parameters and DCE-MRI quantitative parameters was good to excellent (intraclass correlation coefficient = 0.8618-0.9181, intraclass correlation coefficient = 0.7826-0.9088, respectively). Moderate correlations were found between f·D* and Ktrans (r = 0.533; p < 0.001), and relatively weak correlations between D* and Ktrans (r = 0.389; p < 0.001), D* and Vp (r = 0.442; p < 0.001), f·D* and Vp (r = 0.466; p < 0.001), and f and Vp (r = -0.234; p = 0.021).
CONCLUSION: IVIM perfusion-related parameters, especially f·D*, demonstrated moderate correlations with DCE-MRI quantitative parameters in rectal cancer.
Copyright © 2018 The Association of University Radiologists. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Rectal cancer; dynamic contrast-enhanced; intravoxel incoherent motion; magnetic resonance imaging

Year:  2018        PMID: 30268719     DOI: 10.1016/j.acra.2018.08.012

Source DB:  PubMed          Journal:  Acad Radiol        ISSN: 1076-6332            Impact factor:   3.173


  4 in total

1.  Diffusion-weighted and dynamic contrast-enhanced magnetic resonance imaging after radiation therapy for bone metastases in patients with hepatocellular carcinoma.

Authors:  Ji Hyun Lee; Gyu Sang Yoo; Young Cheol Yoon; Hee Chul Park; Hyun Su Kim
Journal:  Sci Rep       Date:  2021-05-17       Impact factor: 4.379

2.  Comparison of Intravoxel incoherent motion imaging and multiecho dynamic contrast-based MRI in rectal cancer.

Authors:  Kine Mari Bakke; Endre Grøvik; Sebastian Meltzer; Anne Negård; Stein Harald Holmedal; Lars Tore G Mikalsen; Lars Gustav Lyckander; Anne H Ree; Kjell-Inge Gjesdal; Kathrine R Redalen; Atle Bjørnerud
Journal:  J Magn Reson Imaging       Date:  2019-04-04       Impact factor: 4.813

Review 3.  Quantitative Magnetic Resonance Imaging for Biological Image-Guided Adaptive Radiotherapy.

Authors:  Petra J van Houdt; Yingli Yang; Uulke A van der Heide
Journal:  Front Oncol       Date:  2021-01-29       Impact factor: 6.244

4.  DCE-MRI is more sensitive than IVIM-DWI for assessing anti-angiogenic treatment-induced changes in colorectal liver metastases.

Authors:  Mihaela Rata; Khurum Khan; David J Collins; Dow-Mu Koh; Nina Tunariu; Maria Antonietta Bali; James d'Arcy; Jessica M Winfield; Simona Picchia; Nicola Valeri; Ian Chau; David Cunningham; Matteo Fassan; Martin O Leach; Matthew R Orton
Journal:  Cancer Imaging       Date:  2021-12-19       Impact factor: 3.909

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.